1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
- A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer
- 2006
- Independent risk factors for anemia in cancer patients receiving chemotherapy: Results from the European Cancer Anaemia Survey
- 2005
- Cancer-related anemia: Pathogenesis, prevalence and treatment
- Cancer-related anemia: Biological findings, clinical implications and impact on quality of life
- 2004
- Raltitrexed plus Gemcitabine (TOMGEM) in advanced pancreatic cancer - Results of a Belgian Multicentre Phase II Study
- 1997
- Ondansetron suppository: A randomised, double-blind, double-dummy, parallel-group comparison with oral ondansetron for the prevention of cyclophosphamide-induced emesis and nausea.
- 1981
- Effect of anticancer agents on invasion of mouse fibrosarcoma cells in vitro.
- 1978
- Methyl[5-(2-thienylcarbonyl)-1H-Benzimidazole-2-yl] Carbamate (R17934), a synthetic microtubule inhibitor, prevents malignant invasion in vitro.
- 1977
- Invasion of malignant cells into 51Cr-labeled host tissues in organotypical culture.